# Manufacture of Clinical T-cell Products for Future Treatment

> **NCT05713513** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 9 (actual)

## Conditions studied

- Virus-specific T Cells

## Interventions

- **OTHER:** Leukapheresis

## Key facts

- **NCT ID:** NCT05713513
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-24
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713513, "Manufacture of Clinical T-cell Products for Future Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05713513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*